SCHEDULE 13G FOR ATYR PHARMA, INC.

Company

aTYR PHARMA INC

Filed

January 19, 2016

Accession Number

0000904454-16-000875

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →